NRX Pharmaceuticals (NRXP) Times Interest Earned (2017 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly Times Interest Earned of -$20.35 for Q1 2026, down 30.72% quarter-over-quarter from -$15.57 in Q4 2025.
NRX Pharmaceuticals (NRXP) Times Interest Earned (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Times Interest Earned for 8 consecutive years, with -$20.35 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned changed N/A year-over-year to -$20.35; the TTM figure through Mar 2026 stood at -$32.3 (up 54.56% YoY), while the FY2025 annual figure was -$0.32, up 14.94% from the prior year.
- Times Interest Earned slipped to -$20.35 in Q1 2026 per NRXP's latest filing, from -$15.57 in the prior quarter.
- Across five years, Times Interest Earned topped out at $16.89 in Q4 2024 and bottomed at -$178.0 in Q2 2023.
- Historically, Times Interest Earned has averaged -$31.41 across 5 years, with a median of -$20.35 in 2026.
- Annual changes were most pronounced in 2022 — Times Interest Earned plunged 6526.46% — and 2024, when it surged 170.91%.
- NRX Pharmaceuticals' Times Interest Earned stood at -$3.88 in 2022, then tumbled by 513.95% to -$23.82 in 2023, then soared by 170.91% to $16.89 in 2024, then slumped by 192.19% to -$15.57 in 2025, then sank by 30.72% to -$20.35 in 2026.
- Business Quant data shows NRXP's Times Interest Earned at -$20.35 in Q1 2026, -$15.57 in Q4 2025, and -$21.29 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 | -27.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.35 |
| Dec 31, 2025 | -15.57 |
| Sep 30, 2025 | -21.29 |
| Dec 31, 2024 | 16.89 |
| Mar 31, 2024 | -16.04 |
| Dec 31, 2023 | -23.82 |
| Sep 30, 2023 | -11.62 |
| Jun 30, 2023 | -178.00 |
| Mar 31, 2023 | -31.02 |
| Dec 31, 2022 | -3.88 |
| Sep 30, 2022 | -32.88 |
| Jun 30, 2022 | -55.17 |
| Mar 31, 2022 | -15.61 |
| Dec 31, 2021 | -26,487.50 |
| Sep 30, 2021 | -1.61 |
| Jun 30, 2021 | -0.83 |
| Mar 31, 2021 | -0.84 |
| Dec 31, 2020 | -9,635.41 |
| Sep 30, 2020 | -411.51 |
| Jun 30, 2020 | 41.40 |